Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN53688797
ISRCTN53688797
Completed
N/A

Quantitative assessment of myocardial perfusion with magnetic resonance using an intravascular contrast agent: an open label trial

King's College London (UK)0 sites156 target enrollmentNovember 13, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCoronary artery diseaseCirculatory SystemChronic ischaemic heart disease

Overview

Phase
N/A
Intervention
Not specified
Conditions
Coronary artery disease
Sponsor
King's College London (UK)
Enrollment
156
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 13, 2009
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
King's College London (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Known coronary artery disease (with or without prior percutaneous revascularisation)
  • •2\. Indication for percutaneous coronary intervention (PCI)
  • •3\. The subject is 18 years of age or older, either sex
  • •4\. The subject is conscious and able to comply with study procedures
  • •5\. Written informed consent has been obtained

Exclusion Criteria

  • •1\. Contraindications for magnetic resonance imaging (MRI)
  • •2\. Contraindications to gadolinium\-based contrast agents (known allergies or a contra\-indication to gadolinium (Gd) chelates or renal insufficiency)
  • •3\. Contraindications to adenosine stress:
  • •3\.1\. Myocardial infarction less than 3 days
  • •3\.2\. Unstable angina pectoris
  • •3\.3\. Severe arterial hypertension
  • •3\.4\. Asthma or severe obstructive pulmonary disease requiring treatment (chronic obstructive pulmonary disease \[COPD])
  • •3\.5\. Sick sinus syndrome or a symptomatic bradycardia, atrioventricular (AV) block greater than IIa, trifascicular block
  • •3\.6\. Allergy against vasodilator
  • •3\.7\. Allergy against gadolinium\-based contrast agents or renal insufficiency

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
N/A
Quantitative Assessment of Myocardial Perfusion with Magnetic Resonance Using an Intravascular Contrast AgentIschemic cardiomyopathy, with inducible ischemia and clinical indication to cardiac revascularizationMedDRA version: 9.1Level: LLTClassification code 10055217Term: Ischemic cardiomyopathy
EUCTR2008-004895-39-GBKing's College London
Completed
N/A
Assessment of Myocardial Perfusion Linked to Infarction and Fibrosis Explored with DSCT.
JPRN-UMIN000016353Department of Radiology,Mie University Graduate School of Medicine200
Active, Not Recruiting
N/A
Comparison of two medicines in heartr perfusion stress studies.
EUCTR2013-001225-11-FITurku University Hospital30
Completed
N/A
Quantification of Myocardial Blood Flow Using Low-Dose Dynamic 320-row Multi-detector CT as Compared With 15O-H2O PETcoronary artery disease
JPRN-UMIN000011883Department of Radiation Medicine, Hokkaido University Graduate School of Medicine65
Recruiting
Phase 3
Accuracy of quantification of myocardial blood flow by Dynamic Stress Perfusion CT: verification with 15O-H2O PETKnown or suspected chronic coronary artery diseaseChronic coronary artery diseaseD003324
JPRN-jRCTs042220045Ichikawa Yasutaka47